Taranabant
- Generic Name
- Taranabant
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H25ClF3N3O2
- CAS Number
- 701977-09-5
- Unique Ingredient Identifier
- X9U622S114
- Indication
Investigated for use/treatment in obesity.
- Associated Conditions
- -
- Associated Therapies
- -
An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED)
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-02-02
- Last Posted Date
- 2015-02-13
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 600
- Registration Number
- NCT00430742
A Weight Maintenance Study in Obese Patients (0364-012)(TERMINATED)
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2015-02-05
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 1000
- Registration Number
- NCT00420589
An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED)
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2015-03-13
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 1000
- Registration Number
- NCT00384605
A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)
- First Posted Date
- 2005-08-18
- Last Posted Date
- 2015-02-05
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 2400
- Registration Number
- NCT00131404
An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-08-18
- Last Posted Date
- 2016-06-07
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 500
- Registration Number
- NCT00131430
A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-04-25
- Last Posted Date
- 2015-09-25
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 300
- Registration Number
- NCT00109135
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath